Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Calcium N5-Methyltetrahydrofolate

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    5-MTHF Found Viable Alternative to Folic Acid in Late Pregnancy
    5-MTHF Found Viable Alternative to Folic Acid in Late Pregnancy

    07 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/new-findings-suggest-5-mthf-is-a-viable-alternative-to-folic-acid-during-second-and-third-trimester-supporting-folate-status-while-reducing-excess-folic-acid-in-circulation-302765060.html

    PR NEWSWIRE
    07 May 2026
    Share Share
    Anvisa Approves Cabometyx (capazantinib levomalate) for advanced or metastatic kidney cancer
    Anvisa Approves Cabometyx (capazantinib levomalate) for advanced or metastatic kidney cancer

    19 Oct 2018

    // ANVISA

    https://www.pharmacompass.com/pdf/news/anvisa-approves-cabometyx-capazantinib-levomalate-for-advanced-or-metastatic-kidney-cancer-1540289804.pdf

    ANVISA
    19 Oct 2018
    Share Share
    Lupin launches contraceptive drug in the US market
    Lupin launches contraceptive drug in the US market

    27 Aug 2018

    // ECONOMIC TIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-contraceptive-drug-in-the-us-market/articleshow/65560450.cms

    ECONOMIC TIMES
    27 Aug 2018
    Share Share
    Lupin`s Generic Drospirenone: Levomefolate Calcium: Estradiol Receives Approval In US
    Lupin`s Generic Drospirenone: Levomefolate Calcium: Estradiol Receives Approval In US

    15 Jun 2018

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205947

    FDA
    15 Jun 2018
    Share Share
    Lupin gets USFDA nod for contraceptive tablet 'Tydemy' for women
    Lupin gets USFDA nod for contraceptive tablet 'Tydemy' for women

    13 Mar 2018

    // BUSINESS-STANDARD

    http://www.business-standard.com/article/companies/lupin-gets-usfda-nod-for-contraceptive-tablet-tydemy-for-women-118031300647_1.html

    BUSINESS-STANDARD
    13 Mar 2018
    Share Share
    Lupin’s Generic Tydemy (Drospirenone; Ethinyl Estradiol; Levomefolate Calcium ) Receives Approval In US
    Lupin’s Generic Tydemy (Drospirenone; Ethinyl Estradiol; Levomefolate Calcium ) Receives Approval In US

    16 Dec 2017

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205948

    FDA
    16 Dec 2017
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.